Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May-Jun;15(3):275-280.
doi: 10.1016/j.orcp.2021.02.008. Epub 2021 Mar 3.

Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry

Mohammad Abumayyaleh  1 , Iván J Núñez Gil  2 , Ibrahim El-Battrawy  3 , Vicente Estrada  4 , Víctor Manuel Becerra-Muñoz  5 , Alvaro Aparisi  6 , Inmaculada Fernández-Rozas  7 , Gisela Feltes  8 , Ramón Arroyo-Espliguero  9 , Daniela Trabattoni  10 , Javier López-País  11 , Martino Pepe  12 , Rodolfo Romero  13 , Diego Raúl Villavicencio García  14 , Carloalberto Biole  15 , Thamar Capel Astrua  16 , Charbel Maroun Eid  17 , Emilio Alfonso  18 , Lucia Fernandez-Presa  19 , Carolina Espejo  20 , Danilo Buonsenso  21 , Sergio Raposeiras  22 , Cristina Fernández  23 , Carlos Macaya  4 , Ibrahim Akin  3 ; HOPE COVID-19 investigators
Affiliations

Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry

Mohammad Abumayyaleh et al. Obes Res Clin Pract. 2021 May-Jun.

Abstract

Background: Obesity has been described as a protective factor in cardiovascular and other diseases being expressed as 'obesity paradox'. However, the impact of obesity on clinical outcomes including mortality in COVID-19 has been poorly systematically investigated until now. We aimed to compare clinical outcomes among COVID-19 patients divided into three groups according to the body mass index (BMI).

Methods: We retrospectively collected data up to May 31st, 2020. 3635 patients were divided into three groups of BMI (<25 kg/m2; n = 1110, 25-30 kg/m2; n = 1464, and >30 kg/m2; n = 1061). Demographic, in-hospital complications, and predictors for mortality, respiratory insufficiency, and sepsis were analyzed.

Results: The rate of respiratory insufficiency was more recorded in BMI 25-30 kg/m2 as compared to BMI < 25 kg/m2 (22.8% vs. 41.8%; p < 0.001), and in BMI > 30 kg/m2 than BMI < 25 kg/m2, respectively (22.8% vs. 35.4%; p < 0.001). Sepsis was more observed in BMI 25-30 kg/m2 and BMI > 30 kg/m2 as compared to BMI < 25 kg/m2, respectively (25.1% vs. 42.5%; p = 0.02) and (25.1% vs. 32.5%; p = 0.006). The mortality rate was higher in BMI 25-30 kg/m2 and BMI > 30 kg/m2 as compared to BMI < 25 kg/m2, respectively (27.2% vs. 39.2%; p = 0.31) (27.2% vs. 33.5%; p = 0.004). In the Cox multivariate analysis for mortality, BMI < 25 kg/m2 and BMI > 30 kg/m2 did not impact the mortality rate (HR 1.15, 95% CI: 0.889-1.508; p = 0.27) (HR 1.15, 95% CI: 0.893-1.479; p = 0.27). In multivariate logistic regression analyses for respiratory insufficiency and sepsis, BMI < 25 kg/m2 is determined as an independent predictor for reduction of respiratory insufficiency (OR 0.73, 95% CI: 0.538-1.004; p = 0.05).

Conclusions: HOPE COVID-19-Registry revealed no evidence of obesity paradox in patients with COVID-19. However, Obesity was associated with a higher rate of respiratory insufficiency and sepsis but was not determined as an independent predictor for a high mortality.

Keywords: BMI; COVID-19; Obesity paradox; SARS-CoV-2.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow chart of study selection process.
Fig. 2
Fig. 2
Survival analysis in normal weight, overweight, and obese patients with COVID-19.
Fig. 3
Fig. 3
Predictors for mortality, sepsis, and respiratory insufficiency. Abbreviations: BMI, body mass index; SPO2, peripheral oxygen saturation; ECMO, extracorporeal membrane oxygenation.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bluher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288–298. - PubMed
    1. Wiebe N., Stenvinkel P., Tonelli M. Associations of chronic inflammation, insulin resistance, and severe obesity with mortality, myocardial infarction, cancer, and chronic pulmonary disease. JAMA Netw Open. 2019;2(8) - PMC - PubMed
    1. Van Kerkhove M.D., Vandemaele K.A., Shinde V., Jaramillo-Gutierrez G., Koukounari A. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med. 2011;8(7) - PMC - PubMed
    1. Baik I., Curhan G.C., Rimm E.B., Bendich A., Willett W.C., Fawzi W.W. A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. Arch Intern Med. 2000;160(20):3082–3088. - PubMed
    1. Petrakis D., Margina D., Tsarouhas K., Tekos F., Stan M., Nikitovic D. Obesity a risk factor for increased COVID19 prevalence, severity and lethality (review) Mol Med Rep. 2020;22(1):9–19. - PMC - PubMed